BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17161124)

  • 1. Provider practice models for and costs of delivering medication abortion -- evidence from 11 US abortion care settings.
    Afable-Munsuz A; Gould H; Stewart F; Phillips KA; Van Bebber SL; Moore C
    Contraception; 2007 Jan; 75(1):45-51. PubMed ID: 17161124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient costs for medication abortion: results from a study of five clinical practices.
    Van Bebber SL; Phillips KA; Weitz TA; Gould H; Stewart F
    Womens Health Issues; 2006; 16(1):4-13. PubMed ID: 16487919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical abortion practices: a survey of National Abortion Federation members in the United States.
    Wiegerinck MM; Jones HE; O'Connell K; Lichtenberg ES; Paul M; Westhoff CL
    Contraception; 2008 Dec; 78(6):486-91. PubMed ID: 19014795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
    Creinin MD; Shore E; Balasubramanian S; Harwood B
    Contraception; 2005 Jan; 71(1):26-30. PubMed ID: 15639068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the costs and economic consequences of unsafe abortion in Mexico City before legalisation.
    Levin C; Grossman D; Berdichevsky K; Diaz C; Aracena B; Garcia SG; Goodyear L
    Reprod Health Matters; 2009 May; 17(33):120-32. PubMed ID: 19523589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The harassment of U.S. abortion providers.
    Forrest JD; Henshaw SK
    Fam Plann Perspect; 1987; 19(1):9-13. PubMed ID: 3556539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early abortion in Ontario: options and costs.
    Limacher JJ; Daniel I; Isaacksz S; Payne GJ; Dunn S; Coyte PC; Laporte A
    J Obstet Gynaecol Can; 2006 Feb; 28(2):142-8. PubMed ID: 16643717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of abortion service providers in two northern Indian states.
    Creanga AA; Roy P; Tsui AO
    Contraception; 2008 Dec; 78(6):500-6. PubMed ID: 19014797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?
    Leeman L; Asaria S; Espey E; Ogburn J; Gopman S; Barnett S
    Contraception; 2007 Aug; 76(2):96-100. PubMed ID: 17656177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incarcerated women and abortion provision: a survey of correctional health providers.
    Sufrin CB; Creinin MD; Chang JC
    Perspect Sex Reprod Health; 2009 Mar; 41(1):6-11. PubMed ID: 19291123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City.
    Hu D; Grossman D; Levin C; Blanchard K; Goldie SJ
    BJOG; 2009 May; 116(6):768-79. PubMed ID: 19432565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of postabortion care and legal abortion in Colombia.
    Prada E; Maddow-Zimet I; Juarez F
    Int Perspect Sex Reprod Health; 2013 Sep; 39(3):114-23. PubMed ID: 24135043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
    Tamang A; Tamang J
    Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical process variation: effect on quality and cost of care.
    Moore CL; McMullen MJ; Woolford SW; Berger BM
    Am J Manag Care; 2010 May; 16(5):385-92. PubMed ID: 20469959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abortion in the United States: incidence and access to services, 2005.
    Jones RK; Zolna MR; Henshaw SK; Finer LB
    Perspect Sex Reprod Health; 2008 Mar; 40(1):6-16. PubMed ID: 18318867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the costs of delivering routine immunization services in Peru.
    Walker D; Mosqueira NR; Penny ME; Lanata CF; Clark AD; Sanderson CF; Fox-Rushby JA
    Bull World Health Organ; 2004 Sep; 82(9):676-82. PubMed ID: 15628205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactions to medical abortion among providers of surgical abortion: an early snapshot.
    Joffe C
    Fam Plann Perspect; 1999; 31(1):35-8. PubMed ID: 10029931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "You can't do that 'round here": a case study of the introduction of medical abortion care at a University Medical Center.
    Leeman L; Espey E
    Contraception; 2005 Feb; 71(2):84-8. PubMed ID: 15707555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequently asked questions about medical abortion.
    von Hertzen H; Baird D;
    Contraception; 2006 Jul; 74(1):3-10. PubMed ID: 16781252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.